|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3993073A
(en)
|
1969-04-01 |
1976-11-23 |
Alza Corporation |
Novel drug delivery device
|
|
US3598122A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3710795A
(en)
|
1970-09-29 |
1973-01-16 |
Alza Corp |
Drug-delivery device with stretched, rate-controlling membrane
|
|
US4069307A
(en)
|
1970-10-01 |
1978-01-17 |
Alza Corporation |
Drug-delivery device comprising certain polymeric materials for controlled release of drug
|
|
US3731683A
(en)
|
1971-06-04 |
1973-05-08 |
Alza Corp |
Bandage for the controlled metering of topical drugs to the skin
|
|
US3742951A
(en)
|
1971-08-09 |
1973-07-03 |
Alza Corp |
Bandage for controlled release of vasodilators
|
|
US3996934A
(en)
|
1971-08-09 |
1976-12-14 |
Alza Corporation |
Medical bandage
|
|
BE795384A
(fr)
|
1972-02-14 |
1973-08-13 |
Ici Ltd |
Pansements
|
|
US3921636A
(en)
|
1973-01-15 |
1975-11-25 |
Alza Corp |
Novel drug delivery device
|
|
US3993072A
(en)
|
1974-08-28 |
1976-11-23 |
Alza Corporation |
Microporous drug delivery device
|
|
US4151273A
(en)
|
1974-10-31 |
1979-04-24 |
The Regents Of The University Of California |
Increasing the absorption rate of insoluble drugs
|
|
US3972995A
(en)
|
1975-04-14 |
1976-08-03 |
American Home Products Corporation |
Dosage form
|
|
US4077407A
(en)
|
1975-11-24 |
1978-03-07 |
Alza Corporation |
Osmotic devices having composite walls
|
|
US4031894A
(en)
|
1975-12-08 |
1977-06-28 |
Alza Corporation |
Bandage for transdermally administering scopolamine to prevent nausea
|
|
US4060084A
(en)
|
1976-09-07 |
1977-11-29 |
Alza Corporation |
Method and therapeutic system for providing chemotherapy transdermally
|
|
US4201211A
(en)
|
1977-07-12 |
1980-05-06 |
Alza Corporation |
Therapeutic system for administering clonidine transdermally
|
|
JPS5562012A
(en)
|
1978-11-06 |
1980-05-10 |
Teijin Ltd |
Slow-releasing preparation
|
|
US4230105A
(en)
|
1978-11-13 |
1980-10-28 |
Merck & Co., Inc. |
Transdermal delivery of drugs
|
|
US4229447A
(en)
|
1979-06-04 |
1980-10-21 |
American Home Products Corporation |
Intraoral methods of using benzodiazepines
|
|
CA1146866A
(en)
|
1979-07-05 |
1983-05-24 |
Yamanouchi Pharmaceutical Co. Ltd. |
Process for the production of sustained release pharmaceutical composition of solid medical material
|
|
US4291015A
(en)
|
1979-08-14 |
1981-09-22 |
Key Pharmaceuticals, Inc. |
Polymeric diffusion matrix containing a vasodilator
|
|
US4327725A
(en)
|
1980-11-25 |
1982-05-04 |
Alza Corporation |
Osmotic device with hydrogel driving member
|
|
US5116817A
(en)
|
1982-12-10 |
1992-05-26 |
Syntex (U.S.A.) Inc. |
LHRH preparations for intranasal administration
|
|
US4476116A
(en)
|
1982-12-10 |
1984-10-09 |
Syntex (U.S.A.) Inc. |
Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
|
|
US4596795A
(en)
|
1984-04-25 |
1986-06-24 |
The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services |
Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
|
|
US4624848A
(en)
|
1984-05-10 |
1986-11-25 |
Ciba-Geigy Corporation |
Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
|
|
GB8518301D0
(en)
|
1985-07-19 |
1985-08-29 |
Fujisawa Pharmaceutical Co |
Hydrodynamically explosive systems
|
|
JPH0778017B2
(ja)
|
1985-12-28 |
1995-08-23 |
住友製薬株式会社 |
パルス的かつ持続放出性製剤
|
|
US4755386A
(en)
|
1986-01-22 |
1988-07-05 |
Schering Corporation |
Buccal formulation
|
|
US5312325A
(en)
|
1987-05-28 |
1994-05-17 |
Drug Delivery Systems Inc |
Pulsating transdermal drug delivery system
|
|
US4968509A
(en)
|
1987-07-27 |
1990-11-06 |
Mcneilab, Inc. |
Oral sustained release acetaminophen formulation and process
|
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
|
US5033252A
(en)
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
|
IL92966A
(en)
|
1989-01-12 |
1995-07-31 |
Pfizer |
Dispensing devices powered by hydrogel
|
|
PH27357A
(en)
|
1989-09-22 |
1993-06-21 |
Fujisawa Pharmaceutical Co |
Pyrazole derivatives and pharmaceutical compositions comprising the same
|
|
US5739136A
(en)
|
1989-10-17 |
1998-04-14 |
Ellinwood, Jr.; Everett H. |
Intraoral dosing method of administering medicaments
|
|
US5017381A
(en)
|
1990-05-02 |
1991-05-21 |
Alza Corporation |
Multi-unit pulsatile delivery system
|
|
US5633009A
(en)
|
1990-11-28 |
1997-05-27 |
Sano Corporation |
Transdermal administration of azapirones
|
|
EP0580860B2
(en)
|
1991-04-16 |
2004-12-15 |
Nippon Shinyaku Company, Limited |
Method of manufacturing solid dispersion
|
|
CA2122479C
(en)
|
1991-11-22 |
1998-08-25 |
Richard John Dansereau |
Risedronate delayed-release compositions
|
|
US5229135A
(en)
|
1991-11-22 |
1993-07-20 |
Prographarm Laboratories |
Sustained release diltiazem formulation
|
|
US5340591A
(en)
|
1992-01-24 |
1994-08-23 |
Fujisawa Pharmaceutical Co., Ltd. |
Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine
|
|
US5461140A
(en)
|
1992-04-30 |
1995-10-24 |
Pharmaceutical Delivery Systems |
Bioerodible polymers for solid controlled release pharmaceutical compositions
|
|
US5260068A
(en)
|
1992-05-04 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Multiparticulate pulsatile drug delivery system
|
|
US5281420A
(en)
|
1992-05-19 |
1994-01-25 |
The Procter & Gamble Company |
Solid dispersion compositions of tebufelone
|
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
AU4198793A
(en)
|
1992-07-24 |
1994-01-27 |
Takeda Chemical Industries Ltd. |
Microparticle preparation and production thereof
|
|
US5700485A
(en)
|
1992-09-10 |
1997-12-23 |
Children's Medical Center Corporation |
Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
|
|
DE69332291T2
(de)
|
1992-10-16 |
2003-07-31 |
Nippon Shinyaku Co., Ltd. |
Verfahren zur herstellung von wachsmatrizes
|
|
US5260069A
(en)
|
1992-11-27 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Pulsatile particles drug delivery system
|
|
US5604260A
(en)
|
1992-12-11 |
1997-02-18 |
Merck Frosst Canada Inc. |
5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
|
|
ATE160345T1
(de)
|
1993-01-15 |
1997-12-15 |
Searle & Co |
3,4-diarylthiophene und analoga davon, sowie deren verwendung als entzündungshemmende mittel
|
|
US5686105A
(en)
|
1993-10-19 |
1997-11-11 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
|
US5409944A
(en)
|
1993-03-12 |
1995-04-25 |
Merck Frosst Canada, Inc. |
Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase
|
|
US5380738A
(en)
|
1993-05-21 |
1995-01-10 |
Monsanto Company |
2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
|
|
GB9602877D0
(en)
|
1996-02-13 |
1996-04-10 |
Merck Frosst Canada Inc |
3,4-Diaryl-2-hydroxy-2,5- dihydrofurans as prodrugs to cox-2 inhibitors
|
|
US5436265A
(en)
|
1993-11-12 |
1995-07-25 |
Merck Frosst Canada, Inc. |
1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents
|
|
US5474995A
(en)
|
1993-06-24 |
1995-12-12 |
Merck Frosst Canada, Inc. |
Phenyl heterocycles as cox-2 inhibitors
|
|
US5344991A
(en)
|
1993-10-29 |
1994-09-06 |
G.D. Searle & Co. |
1,2 diarylcyclopentenyl compounds for the treatment of inflammation
|
|
US5466823A
(en)
|
1993-11-30 |
1995-11-14 |
G.D. Searle & Co. |
Substituted pyrazolyl benzenesulfonamides
|
|
US5393790A
(en)
|
1994-02-10 |
1995-02-28 |
G.D. Searle & Co. |
Substituted spiro compounds for the treatment of inflammation
|
|
US5665378A
(en)
|
1994-09-30 |
1997-09-09 |
Davis; Roosevelt |
Transdermal therapeutic formulation
|
|
US5633272A
(en)
|
1995-02-13 |
1997-05-27 |
Talley; John J. |
Substituted isoxazoles for the treatment of inflammation
|
|
US5567441A
(en)
|
1995-03-24 |
1996-10-22 |
Andrx Pharmaceuticals Inc. |
Diltiazem controlled release formulation
|
|
KR19990014865A
(ko)
|
1995-05-17 |
1999-02-25 |
피터 이. 브래이브맨 |
소장에서의 소화 및 흡수를 증진시키기 위한, 지방산을 함유한조성물들
|
|
SE9502244D0
(sv)
|
1995-06-20 |
1995-06-20 |
Bioglan Ab |
A composition and a process for the preparation thereof
|
|
US6020343A
(en)
|
1995-10-13 |
2000-02-01 |
Merck Frosst Canada, Inc. |
(Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
|
|
GB9523946D0
(en)
|
1995-11-23 |
1996-01-24 |
Bayer Ag |
Leukotriene antagonistic benzoic acid derivatives
|
|
US5837284A
(en)
|
1995-12-04 |
1998-11-17 |
Mehta; Atul M. |
Delivery of multiple doses of medications
|
|
US5858401A
(en)
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
|
US6923983B2
(en)
|
1996-02-19 |
2005-08-02 |
Acrux Dds Pty Ltd |
Transdermal delivery of hormones
|
|
US6929801B2
(en)
|
1996-02-19 |
2005-08-16 |
Acrux Dds Pty Ltd |
Transdermal delivery of antiparkinson agents
|
|
BR9708574A
(pt)
|
1996-04-12 |
1999-08-03 |
Searle & Co |
Derivados benzeno sulfonamida substituídos como pródrogas de inibidores cox-2
|
|
US5861419A
(en)
|
1996-07-18 |
1999-01-19 |
Merck Frosst Canad, Inc. |
Substituted pyridines as selective cyclooxygenase-2 inhibitors
|
|
US6093723A
(en)
|
1996-08-09 |
2000-07-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
4-substituted beta-carbolines and analogs thereof
|
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US5840329A
(en)
|
1997-05-15 |
1998-11-24 |
Bioadvances Llc |
Pulsatile drug delivery system
|
|
US6391452B1
(en)
|
1997-07-18 |
2002-05-21 |
Bayer Corporation |
Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
|
|
AU751139B2
(en)
|
1997-10-13 |
2002-08-08 |
Astellas Pharma Inc. |
Amide derivative
|
|
US6022884A
(en)
*
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
|
US5869090A
(en)
|
1998-01-20 |
1999-02-09 |
Rosenbaum; Jerry |
Transdermal delivery of dehydroepiandrosterone
|
|
CA2327185A1
(en)
|
1998-04-08 |
1999-10-14 |
Abbott Laboratories |
Pyrazole inhibitors of cytokine production
|
|
CA2332957A1
(en)
|
1998-06-05 |
1999-12-09 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
|
|
US6946144B1
(en)
|
1998-07-08 |
2005-09-20 |
Oryxe |
Transdermal delivery system
|
|
DE60039379D1
(de)
|
1999-02-10 |
2008-08-21 |
Pfizer Prod Inc |
Pharmazeutische feste Dispersionen
|
|
US20010044445A1
(en)
|
1999-04-08 |
2001-11-22 |
Bamaung Nwe Y. |
Azole inhibitors of cytokine production
|
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
BR0013469B1
(pt)
*
|
1999-08-20 |
2011-01-25 |
|
amidas aromáticas heterocìclicas fungicidas, composição fungicida compreendendo as mesmas, bem como método para o controle ou a prevenção de infestação fúngica.
|
|
JP3910319B2
(ja)
*
|
1999-09-13 |
2007-04-25 |
株式会社小糸製作所 |
自動車用灯具
|
|
JP2001089412A
(ja)
*
|
1999-09-22 |
2001-04-03 |
Otsuka Pharmaceut Co Ltd |
ベンゼン誘導体またはその医薬的に許容される塩
|
|
US6313138B1
(en)
|
2000-02-25 |
2001-11-06 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
EP1143013A1
(en)
|
2000-04-03 |
2001-10-10 |
Warner-Lambert Company |
Methods and compositions for screening Icrac modulators
|
|
US6465014B1
(en)
|
2001-03-21 |
2002-10-15 |
Isp Investments Inc. |
pH-dependent sustained release, drug-delivery composition
|
|
US6960563B2
(en)
|
2001-08-31 |
2005-11-01 |
Morton Grove Pharmaceuticals, Inc. |
Spontaneous emulsions containing cyclosporine
|
|
GB0225554D0
(en)
|
2002-11-01 |
2002-12-11 |
Syngenta Participations Ag |
Chemical compounds
|
|
ES2571779T3
(es)
*
|
2002-12-13 |
2016-05-26 |
Ym Biosciences Australia Pty |
Inhibidores de cinasa a base de nicotinamida
|
|
WO2004056774A2
(en)
*
|
2002-12-19 |
2004-07-08 |
Neurogen Corporation |
Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
|
|
US7645588B2
(en)
|
2003-03-04 |
2010-01-12 |
Calcimedica, Inc. |
Composition comprising a cell comprising a STIM1 protein and an agent that modulates intracellular calcium and methods of use
|
|
EP1638551B1
(en)
|
2003-05-19 |
2011-12-21 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
HRP20110180T1
(hr)
|
2003-07-23 |
2011-04-30 |
Synta Pharmaceuticals Corporation |
Spojevi za upotrebu kod upala i upotrebe vezane uz imunitet
|
|
US20050227929A1
(en)
|
2003-11-13 |
2005-10-13 |
Masferrer Jaime L |
Combination therapy comprising a Cox-2 inhibitor and an antineoplastic agent
|
|
DE102004005785A1
(de)
|
2004-02-06 |
2005-08-25 |
Bayer Cropscience Ag |
2-Halogenfuryl/thienyl-3-carboxamide
|
|
MX2007003342A
(es)
|
2004-09-21 |
2007-06-05 |
Synta Pharmaceutical Corp |
Compuestos para inflamacion y usos relacionados con trastornos inmunitarios.
|
|
KR20140018997A
(ko)
|
2005-01-07 |
2014-02-13 |
신타 파마슈티칼스 코프. |
염증 및 면역 관련 용도를 위한 화합물
|
|
US8802721B2
(en)
|
2005-01-25 |
2014-08-12 |
Synta Pharmaceuticals Corp. |
Thiophene compounds for inflammation and immune-related uses
|
|
TWI422376B
(zh)
|
2005-01-25 |
2014-01-11 |
Synta Pharmaceuticals Corp |
用於炎症及免疫相關用途之化合物
|
|
BRPI0607688A2
(pt)
|
2005-02-17 |
2009-09-22 |
Synta Pharmaceuticals Corp |
método para inibir a polimerização de tubulina em uma célula; método para tratar ou prevenir um distúrbio proliferativo em um indivìduo; método para bloquear, ocluir ou de outro modo romper o fluxo sangüìneo na neovasculatura; composto; composição farmacêutica e uso do referido método e composto
|
|
EP2527337A1
(en)
*
|
2005-04-14 |
2012-11-28 |
Bristol-Myers Squibb Company |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
|
|
EP1937270A1
(en)
|
2005-09-21 |
2008-07-02 |
Brystol-Myers Squibb Company |
Oral administration of n-(2-chloro-6-methylphenyl)-2-[[6-4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof
|
|
ES2778846T3
(es)
*
|
2005-11-08 |
2020-08-12 |
Vertex Pharma |
Moduladores heterocíclicos de transportadores de casete de unión a ATP
|
|
EP1984400B1
(en)
|
2006-01-05 |
2012-11-28 |
Immune Disease Institute, Inc. |
Regulators of nfat
|
|
US7816535B2
(en)
|
2006-01-25 |
2010-10-19 |
Synta Pharmaceuticals Corp. |
Vinyl-phenyl derivatives for inflammation and immune-related uses
|
|
JP2009528273A
(ja)
|
2006-01-25 |
2009-08-06 |
シンタ ファーマシューティカルズ コーポレーション |
炎症および免疫関連使用用の置換ビアリール化合物
|
|
WO2007087429A2
(en)
|
2006-01-25 |
2007-08-02 |
Synta Pharmaceuticals Corp. |
Phenyl and pyridyl compounds for inflammation and immune-related uses
|
|
WO2007087427A2
(en)
|
2006-01-25 |
2007-08-02 |
Synta Pharmaceuticals Corp. |
Thiazole and thiadiazole compounds for inflammation and immune-related uses
|
|
AU2007208239B2
(en)
|
2006-01-25 |
2013-04-18 |
Synta Pharmaceuticals Corp. |
Substituted aromatic compounds for inflammation and immune-related uses
|
|
JP5430944B2
(ja)
|
2006-01-31 |
2014-03-05 |
シンタ ファーマシューティカルズ コーポレーション |
炎症および免疫関連用途のためのピリジルフェニル化合物
|
|
US7951824B2
(en)
|
2006-02-17 |
2011-05-31 |
Hoffman-La Roche Inc. |
4-aryl-pyridine-2-carboxyamide derivatives
|
|
EP2001476A4
(en)
*
|
2006-03-20 |
2010-12-22 |
Synta Pharmaceuticals Corp |
BENZOIMIDAZOLYL-PARAZINE-BASED COMPOUNDS FOR INFLAMMATION USES AND IMMUNE DISORDERS
|
|
AU2007230911A1
(en)
|
2006-03-23 |
2007-10-04 |
Synta Pharmaceuticals Corp. |
Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
|
|
WO2007120600A2
(en)
|
2006-04-10 |
2007-10-25 |
Arena Pharmaceuticals, Inc. |
3-pyridinyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
AU2007322116B2
(en)
|
2006-11-13 |
2013-01-10 |
Synta Pharmaceuticals Corp. |
Cyclohexenyl-aryl compounds for inflammation and immune-related uses
|
|
EP2129219A4
(en)
|
2007-02-16 |
2012-08-29 |
Synta Pharmaceuticals Corp |
SUBSTITUTED FUSED CYCLE COMPOUNDS USED IN CASES OF INFLAMMATION OR IMMUNE DISORDERS
|
|
DK2157979T3
(en)
|
2007-05-24 |
2018-08-27 |
Calcimedica Inc |
CALCIUM CHANNEL PROTEINS AND APPLICATIONS THEREOF
|
|
EP2184994B1
(en)
|
2007-08-01 |
2013-09-25 |
Synta Pharmaceuticals Corp. |
Heterocycle-aryl compounds for inflammation and immune-related uses
|
|
TW200914440A
(en)
|
2007-08-01 |
2009-04-01 |
Synta Pharmaceuticals Corp |
Vinyl-aryl derivatives for inflammation and immune-related uses
|
|
JP2010535769A
(ja)
|
2007-08-09 |
2010-11-25 |
メルク・シャープ・エンド・ドーム・コーポレイション |
ピリジンカルボキサミドオレキシン受容体アンタゴニスト
|
|
US20110052643A1
(en)
|
2008-01-07 |
2011-03-03 |
Synta Pharmaceuticals Corp. |
Compounds for inflammation and immune-related uses
|
|
US20110003859A1
(en)
*
|
2008-02-29 |
2011-01-06 |
Array Biopharma Inc. |
N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer
|
|
US8524763B2
(en)
|
2008-09-22 |
2013-09-03 |
Calcimedica, Inc. |
Inhibitors of store operated calcium release
|
|
WO2010034011A2
(en)
|
2008-09-22 |
2010-03-25 |
Calcimedica, Inc. |
Phenylthiophenyldihydrobenzothiazepine inhibitors of store operated calcium release
|
|
WO2010039237A1
(en)
|
2008-10-01 |
2010-04-08 |
Synta Pharmaceuticals Corp. |
Compounds for inflammation and immune-related uses
|
|
AU2009300318A1
(en)
*
|
2008-10-01 |
2010-04-08 |
Synta Pharmaceuticals Corp. |
Compounds for inflammation and immune-related uses
|
|
EP2421834A1
(en)
|
2009-04-24 |
2012-02-29 |
Glaxo Group Limited |
Pyrazole and triazole carboxamides as crac channel inhibitors
|
|
US20100273744A1
(en)
|
2009-04-24 |
2010-10-28 |
Paul Martin Gore |
Compounds
|
|
US8377970B2
(en)
|
2009-10-08 |
2013-02-19 |
Rhizen Pharmaceuticals Sa |
Modulators of calcium release-activated calcium channel
|
|
US8993612B2
(en)
|
2009-10-08 |
2015-03-31 |
Rhizen Pharmaceuticals Sa |
Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
|
|
US20120231006A1
(en)
|
2009-11-20 |
2012-09-13 |
Amgen Inc. |
Anti-orai1 antigen binding proteins and uses thereof
|
|
WO2011139489A2
(en)
|
2010-04-27 |
2011-11-10 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|